| Han Li; Dorothea Kominos; Jie Zhang; Alla Pritsker; Matthew Davison et al. (2026). Methods for treating inflammation using antibodies to kallidin and des-Arg10-kallidin. Patent Number: US12558420B2. |
|
Patent |
|
| (2013). Fc VARIATIONS AND METHODS FOR PRODUCTION. Patent Number: AR085138A1. |
|
Patent |
|
| Stephen G. Withers; Peter RAHFELD; Jayachandran Kizhakkedathu (2022). ENZYMATIC COMPOSITIONS FOR CLEAVING CARBOHYDRATE ANTIGENS, METHOD, USES, DEVICES AND SYSTEMS ASSOCIATED THEREOF. Patent Number: EP3837370A4. |
|
Patent |
|
| Hongjie Dai; Ming GONG (2016). Heterostructures for ultra-active hydrogen evolution electrocatalysis. Patent Number: WO2016011342A1. |
|
Patent |
|
| Kin S. YANG; Hang CHU; Solomon H. REISBERG; Wai Yan CHOY; Brian P. BESTVATER et al. (2025). Reversible lysine covalent modifiers of cdk2 and uses thereof. Patent Number: WO2025090658A2. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2022). Modulator complex. Patent Number: EP3960759A1. |
|
Patent |
|
| ジョアン・セオアネ・スアレス; ジュディット・アニド・フォルゲイラ; ロビン・マシュー・ハレット; パトリシア・アン・ギブリン; ジェンヌ・マグラム et al. (2023). Combination of LIF inhibitor and platinum-based antineoplastic agent for use in cancer treatment. Patent Number: JP7379390B2. |
|
Patent |
|
| Suri Anish; Sheriff Steven; Suchard Suzanne; Yamniuk Aaron; Krystek Stanley et al. (2018). Antibody polypeptides that antagonize cd40.. Patent Number: MX354243B. |
|
Patent |
|
| ハン・リー; ドロシア・コミノス; ジエ・ジャーン; アラ・プリッツカー; マシュー・ディヴィソン et al. (2024). Antibodies against bradykinin B1 receptor ligand. Patent Number: JP7411609B2. |
|
Patent |
|
| Дж. Майкл ЭЛЛИОТТ; Джастин ШЕЕР (2019). Fc OPTIONS AND METHODS FOR PRODUCING THEM. Patent Number: RU2018108836A. |
|
Patent |
|
| 马塞洛·塞普拉; 王艾舟; 沙菲克·克沙夫吉; 斯蒂芬·G·威瑟斯; 彼得·拉费尔德 et al. (2023). Enzymatic compositions for carbohydrate antigen cleavage on donor organs, methods and uses related thereto. Patent Number: CN112839512B. |
|
Patent |
|
| Kin S. Yang; Hang Chu; Solomon H. Reisberg; Wai Yan Choy; Brian P. Bestvater et al. (2025). Reversible lysine covalent modifiers of cdk2 and uses thereof. Patent Number: US20250289789A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2021). Modulator assay. Patent Number: EP3311169B1. |
|
Patent |
|
| Anish Suri; Steven Sheriff; Suzanne Suchard; Aaron Yamniuk; Stanley Krystek et al. (2013). Antibody polypeptides that antagonize cd40. Patent Number: SG194561A1. |
|
Patent |
|
| Joan Seoane Suarez; Judit Anido Folgueira; Robin Matthew HALLETT; Patricia Anne GIBLIN; Jeanne Magram et al. (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: EP3806899A2. |
|
Patent |
|